Vitrum® Vitamin E (Capsules) Instructions for Use
Marketing Authorization Holder
Unipharm, Inc. (USA)
ATC Code
A11HA03 (Tocopherol (Vitamin E))
Active Substance
Tocopherol (Ph.Eur. European Pharmacopoeia)
Dosage Form
| Vitrum® Vitamin E | Capsules 400 IU: 12, 24, 30 or 60 pcs. |
Dosage Form, Packaging, and Composition
| Capsules | 1 caps. |
| D,L-α-Tocopheryl Acetate | 400 IU |
12 pcs. – blister packs (1) – cardboard packs.
12 pcs. – blister packs (2) – cardboard packs.
60 pcs. – polyethylene bottles (1) – cardboard packs.
Clinical-Pharmacological Group
Vitamin preparation
Pharmacotherapeutic Group
Vitamin
Pharmacological Action
It has antioxidant activity, participates in heme and protein biosynthesis, cell proliferation, tissue respiration, and other crucial processes of tissue metabolism.
It prevents increased permeability and fragility of capillaries, the development of atherosclerosis, degenerative-dystrophic changes in the heart muscle and skeletal muscles; normalizes reproductive function.
Pharmacokinetics
Approximately 50% is slowly absorbed from the gastrointestinal tract, with the maximum blood level reached in about 4 hours.
Bile acids are necessary for absorption.
During absorption, it forms a complex with lipoproteins, which are carriers of vitamin E.
It is stored in the adrenal glands, adipose and muscle tissue, and the liver.
It is metabolized and excreted from the body unchanged and as metabolites with bile (90%) and urine (6%).
Indications
- Treatment of hypovitaminosis, convalescent states after diseases accompanied by febrile syndrome, physical exertion;
- As part of complex therapy for the treatment of cardiovascular diseases, eye diseases;
- As part of measures to prevent atherosclerosis and other diseases of the cardiovascular system in elderly patients;
- Muscular dystrophies, dermatomyositis, amyotrophic lateral sclerosis;
- Degenerative and proliferative changes in the joints and ligamentous apparatus of the spine and large joints;
- Neurasthenia due to overwork, asthenic syndrome;
- Menstrual cycle disorders, climacteric vegetative disorders;
- Dysfunction of the gonads in men;
- Treatment of skin diseases, burns.
ICD codes
| ICD-10 code | Indication |
| E28 | Ovarian dysfunction |
| E29 | Testicular dysfunction |
| E56.0 | Vitamin E deficiency |
| F48.0 | Neurasthenia |
| G12.2 | Motor neuron disease |
| G71.0 | Muscular dystrophy |
| I70 | Atherosclerosis |
| M15 | Polyosteoarthritis |
| M16 | Coxarthrosis [arthrosis of the hip joint] |
| M17 | Gonarthrosis [arthrosis of the knee] |
| M19.9 | Unspecified arthrosis |
| M33 | Dermatopolymyositis |
| M42 | Spinal osteochondrosis |
| M47 | Spondylosis |
| N95.1 | Menopausal and other perimenopausal disorders |
| N95.3 | States associated with artificial menopause |
| T30 | Burns and corrosions of unspecified body region |
| Z54 | Convalescence |
| Z73.0 | Burn-out |
| Z73.3 | Stress, not elsewhere classified (physical and mental strain) |
| ICD-11 code | Indication |
| 4A41.Z | Idiopathic inflammatory myopathy, unspecified |
| 5A80.Z | Ovarian dysfunction, unspecified |
| 5A81.Z | Testicular dysfunction or diseases associated with impaired testosterone production, unspecified |
| 5B58 | Vitamin E deficiency |
| 6A8Z | Affective disorders, unspecified |
| 8B60.Z | Motor neuron disease, unspecified |
| 8B6Y | Other specified motor neuron diseases or related disorders |
| 8B6Z | Motor neuron diseases or related disorders, unspecified |
| 8C70.Z | Muscular dystrophy, unspecified |
| 8D40.1 | Neuropathy due to nutritional deficiency |
| BD40.Z | Atherosclerosis of peripheral arteries, unspecified |
| FA00.Z | Osteoarthritis of hip, unspecified |
| FA01.Z | Osteoarthritis of knee, unspecified |
| FA05 | Polyosteoarthritis |
| FA0Z | Osteoarthritis, unspecified |
| FA85.Z | Defects of vertebral end-plates, unspecified |
| FA8Z | Degenerative disease of spine, unspecified |
| GA30.00 | Menopausal or climacteric states in women |
| GA30.3 | States associated with artificial menopause |
| NE11 | Burn of unspecified body region |
| QB7Z | Convalescence, unspecified |
| QD85 | Burn-out |
| QE01 | Stress, not elsewhere classified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Consult a doctor before use to determine the appropriate dosage and duration of therapy.
Take orally, one 400 IU capsule per day. Swallow the capsule whole with a small amount of water.
Administer during or immediately after a meal to enhance absorption, which requires the presence of bile.
Adhere strictly to the course of administration as prescribed by your physician. Do not exceed the recommended daily dose.
For long-term use at doses exceeding 400 IU daily, do so only under direct medical supervision.
Space the intake of oral iron-containing preparations by at least 8 hours after taking this capsule.
Discontinue use and consult a physician if symptoms of overdose or allergic reactions occur.
Adverse Reactions
When taken in high doses (more than 1 g/day), pain in the upper abdomen, diarrhea, and allergic reactions are possible.
Contraindications
- Hypersensitivity to the drug.
Special Precautions
Exercise caution when using vitamin E in high doses in cases of severe cardiosclerosis, increased risk of embolism, and in the acute period of myocardial infarction.
Overdose
Symptoms: creatinuria, diarrhea, epigastric pain.
If an allergic reaction occurs due to hypersensitivity to the drug, the dose should be reduced or a doctor should be consulted.
Drug Interactions
It enhances the effect of corticosteroids and NSAIDs, cardiac glycosides.
Iron-containing preparations are recommended to be taken orally no earlier than 8 hours after taking vitamin E.
Storage Conditions
Store at room temperature in a dry place, protected from light (ultraviolet rays destroy vitamin E), out of the reach of children, at a temperature below 30°C (86°F).
Shelf Life
Shelf life – 3 years. The drug should not be used after the expiration date.
Dispensing Status
Over-the-counter.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Mildronate capsules 500mg, 90pcs
Fenotropil pills 100mg, 60pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Kagocel pills 12mg, 30pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Noopept, pills 10mg, 50pcs
Picamilon pills 50mg, 60pcs
OKI, sachets 80mg 2g, 12pcs
Cortexin, 10mg, 5ml, 10pcs
Daivobet, ointment, 30g
Actovegin pills 200mg, 50pcs
Belosalic, lotion solution for external use spray 100ml
Ingavirin capsules 90mg, 10pcs
Phenibut-Vertex pills 250mg, 20pcs
Nootropil pills 800mg, 30pcs
Arbidol, capsules 100mg, 40pcs
Belosalic, ointment, 30g 